SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
SEC Accession No. 0001193125-11-307112
Filing Date
2011-11-10
Accepted
2011-11-10 16:55:54
Documents
2
Filing Date Changed
2011-11-10
Effectiveness Date
2011-11-10

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS d255071ddefa14a.htm DEFA14A 62794
2 GRAPHIC g255071g94b10.jpg GRAPHIC 6893
  Complete submission text file 0001193125-11-307112.txt   73459
Mailing Address 929 NORTH FRONT STREET WILMINGTON NC 28401
Business Address 929 NORTH FRONT STREET WILMINGTON NC 28401 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-27570 | Film No.: 111196070
SIC: 8731 Services-Commercial Physical & Biological Research
Assistant Director 1